Allopurinol

Product NDC
43063-976
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Allopurinol
Dosage form
TABLET
Route
ORAL
Labeler
PD-Rx Pharmaceuticals, Inc.
Application
ANDA071450
Marketing category
ANDA
Substance
ALLOPURINOL
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
43063-976-3030 TABLET in 1 BOTTLE, PLASTIC (43063-976-30) 20190820NoHistorical
43063-976-9090 TABLET in 1 BOTTLE, PLASTIC (43063-976-90) 20190429NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
211e47c6-85b9-43e8-9e07-6cc4b8f708a0These highlights do not include all the information needed to use ALLOPURINOL TABLETS safely and effectively. See full prescribing information for ALLOPURINOL TABLETS. ALLOPURINOL tablets, for oral use Initial U.S. Approval: 1966PD-Rx Pharmaceuticals, Inc.2025-10-17HUMAN PRESCRIPTION DRUG LABEL16
211e47c6-85b9-43e8-9e07-6cc4b8f708a0These highlights do not include all the information needed to use ALLOPURINOL TABLETS safely and effectively. See full prescribing information for ALLOPURINOL TABLETS. ALLOPURINOL tablets, for oral use Initial U.S. Approval: 1966PD-Rx Pharmaceuticals, Inc.2024-07-12HUMAN PRESCRIPTION DRUG LABEL15